Manhattan Scientifics, Inc. · OTC:MHTX

Manhattan Scientifics, Inc. financial statements

Manhattan Scientifics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue050.0K50.0K50.0K97.0K0142.0K150.0K64.0K642.0K
Cost of revenue1.00K3.00K2.00K725.0K07.00K189.0K43.0K3.99M3.92M
Gross profit-1.00K50.0K50.0K50.0K97.0K-7.00K-47.0K107.0K64.0K642.0K
Research and development10.0K11.0K10.0K11.0K8.00K52.0K175.0K3.33M2.94M1.86M
Selling, general and administrative693.0K718.0K727.0K714.0K1.11M1.39M2.06M3.20M3.38M2.26M
Operating income-703.0K-679.0K-687.0K-675.0K-1.02M-1.45M-2.28M-6.38M-6.25M-3.47M
Depreciation and amortization1.00K3.00K2.00K2.00K2.00K622.0K857.0K995.0K793.0K202.0K
EBITDA-702.0K-676.0K-685.0K-673.0K-1.02M-826.0K-1.42M-5.39M-5.46M-3.27M
Interest expense021.0K26.0K25.0K5.00K00488.0K675.0K330.0K
Income before tax-1.17M-2.73M-3.64M4.31M-1.22M-8.33M1.55M-6.11M8.01M-3.81M
Income tax-1.17M2.03M26.0K25.0K5.00K-6.89M1.00K488.0K675.0K0
Net income-1.17M-2.73M-3.64M4.31M-1.22M-8.33M1.55M-6.11M8.01M-3.81M
Earnings per share, basic-0.00-0.00-0.010.01-0.00-0.020.00-0.010.01-0.01

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents67.0K175.0K232.0K353.0K261.0K87.0K269.0K1.07M5.36M2.53M
Short-term investments5.88M0000
Receivables300.0K300.0K300.0K44.0K
Inventory-300.0K-300.0K-300.0K0000
Current assets69.0K189.0K547.0K665.0K574.0K98.0K278.0K1.11M5.36M2.53M
Property, plant and equipment4.00K6.00K4.00K6.00K8.00K165.0K291.0K144.0K
Goodwill0000
Total assets316.0K1.03M3.45M6.85M2.23M2.66M10.8M7.63M12.9M3.63M
Accounts payable133.0K119.0K102.0K159.0K234.0K221.0K209.0K472.0K829.0K426.0K
Current liabilities2.12M1.67M1.36M1.01M2.09M1.75M1.63M1.71M1.29M1.79M
Long-term debt104.0K78.0K002.14M1.93M1.62M
Total debt60.0K110.0K130.0K104.0K78.0K2.41M2.38M2.96M
Total liabilities2.12M2.73M2.42M2.17M3.23M2.81M2.69M4.91M4.28M4.46M
Shareholders' equity-1.80M-1.70M1.03M4.67M-1.00M-150.0K8.16M2.72M8.59M-832.0K
Shares outstanding559.3M559.3M559.3M593.1M549.4M533.8M533.8M534.7M593.4M485.6M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-190.0K-349.0K-421.0K-388.0K-316.0K-682.0K-791.0K-4.56M3.42M-2.54M
Capital spending000-4.00K-4.00K-4.00K-8.00K-13.0K-255.0K-36.0K
Free cash flow-190.0K-349.0K-421.0K-392.0K-316.0K-682.0K-799.0K-4.57M3.16M-2.57M
Cash from investing102.0K332.0K300.0K480.0K340.0K500.0K-8.00K-13.0K-255.0K-36.0K
Cash from financing-20.0K-40.0K024.0K150.0K150.0K150.0K275.0K-324.0K4.52M
Dividends paid0000
Share buybacks000-330.0K3.52M
Change in cash-108.0K-57.0K-121.0K92.0K174.0K-182.0K-799.0K-4.30M2.84M1.95M